DataMEDS Terminates Proposed IP Deal; No Shares to Be Issued

DataMEDS terminated its letter of intent for an IP license or acquisition in exchange for common stock, citing market conditions. It said it owes no fees or obligations and will issue no related shares; separate REBOOT and Datavault agreements remain in effect.